Matthew R. Plooster
Chairman
Zevra Therapeutics, Inc. (ZVRA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matthew R. Plooster
Matthew R. Plooster is recorded as Chairman at Zevra Therapeutics, Inc. (ZVRA). Zevra Therapeutics, Inc. reported in an 8-K filed August 7, 2023 that Matthew R. Plooster resigned as member of the Board of the Company, effective August 7, 2023.
“On August 7, 2023, Matthew R. Plooster, a member of the Board of the Company, resigned from such position, effectively immediately after the appointment of Mr. Anderson.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Zevra Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Christal M.M. Mickle CEO
- Neil F. McFarlane CEO, Board Member
- Richard W. Pascoe CEO
- Richard Pascoe Chairman
- Tamara A. Favorito Chairman
- Timothy Sangiovanni CFO
- Alicia Secor Board Member
- Alvin Shih, M.D. Board Member
- Christopher A. Posner Board Member
- Corey Watton Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.